Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

merz pharmaceuticals gmbh - toxina clostridium botulinum tipo a (150 kd) libre de complejo proteico - toxina clostridium botulinum tipo a (150 kd) libre de complejo proteico....100 ui

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

merz pharmaceuticals gmbh - extracto lÍquido de cebolla - extracto lÍquido de cebolla....10 g / heparina sÓdica....0.04 g (5000 ui) / alantoÍna....1 g

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merz pharma uk ltd - botulinum toxin type a - powder for solution for injection - 50unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merz pharma uk ltd - botulinum toxin type a - powder for solution for injection - 100unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merz pharma uk ltd - botulinum toxin type a - powder for solution for injection - 50unit

Singapore - English - HSA (Health Sciences Authority)

merz asia pacific pte. ltd. - general & plastic surgery - radiesse® (+) lidocaine injectable implant is indicated for plastic / reconstructive procedures, including deep dermal and subdermal soft tissue augmentation of the facial area and is also intended for restoration and correction of fat or volume loss (lipoatrophy) in the facial area and for rejuvenation of the hands.

Singapore - English - HSA (Health Sciences Authority)

merz asia pacific pte. ltd. - general & plastic surgery - radiesse® injectable implant is indicated for hand augmentation to correct volume loss in the dorsum of the hands. radiesse® injectable implant is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and it is also intended for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.

United States - English - NLM (National Library of Medicine)

merz north america, inc. - botulinum toxin type a (unii: e211kpy694) (botulinum toxin type a - unii:e211kpy694) - botulinum toxin type a 50 [usp'u] - xeomin is indicated for the treatment of chronic sialorrhea in patients 2 years of age and older. upper limb spasticity in adult patients xeomin is indicated for the treatment of upper limb spasticity in adult patients. upper limb spasticity in pediatric patients, excluding spasticity caused by cerebral palsy xeomin is indicated for the treatment of upper limb spasticity in pediatric patients 2 to 17 years of age, excluding spasticity caused by cerebral palsy. xeomin is indicated for the treatment of cervical dystonia in adult patients. xeomin is indicated for the treatment of blepharospasm in adult patients. xeomin is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients. xeomin is contraindicated in patients with: - known hypersensitivity to any botulinum toxin product or to any of the components in the formulation [see warnings and precautions (5.3) and description (11)] . - infection at t

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

merz pharma gmbh & co. kgaa - extract cepae, heparin (heparin sodium), allantoin - gel for external use - 100mg/g+ 50iu/g+ 10mg/g

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

merz pharma gmbh & co. kgaa - extract cepae, heparin (heparin sodium), allantoin - gel for external use - 100mg/g+ 50iu/g+ 10mg/g